A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study (Q43284690)
scientific article published on 26 August 2009
Language:
Current Data About A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study
(P31) (Q13442814)
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P50) (Q91946596)
(P1545) 1
(P1932) Carol Aghajanian
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P304) 215-220
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P478) 115
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P577) Wednesday, August 26, 2009
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P921) (Q880)
(P887)

(Q5625186)
(P887)

(P1433) (Q5625182)
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P1476) "A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study" (language: en)
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P2093) John A Blessing
(P1545) 2
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Kathleen M Darcy
(P1545) 3
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Gary Reid
(P1545) 4
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Koen DeGeest
(P1545) 5
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Stephen C Rubin
(P1545) 6
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Robert S Mannel
(P1545) 7
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Jacob Rotmensch
(P1545) 8
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Russell J Schilder
(P1545) 9
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

William Riordan
(P1545) 10
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

Gynecologic Oncology Group
(P1545) 11
(P248)
(P698) 19712963
(P813) Saturday, November 18, 2017

(P2860) (Q28255512)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q29618194)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q29614707)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q29618717)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q29614706)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q36580820)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q71693132)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q35663874)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q40979308)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q77764263)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q27860585)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q35124101)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q44211035)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q52231249)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q43675453)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q41034671)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q73042152)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33700949)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q35773857)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q35124091)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q34327233)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q46681064)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33370300)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q46898065)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33364359)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q73932761)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33371505)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33375584)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q79405831)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

(Q33376149)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.023
(P813) Thursday, January 7, 2021

other details
description scientific article published on 26 August 2009

External Links
(P356) 10.1016/J.YGYNO.2009.07.023
(P698) 19712963